Björn Wullt

Filings by Björn Wullt span 2 companies, the busiest being Selectimmun and Selectimmune Pharma AB. The record holds 8 filings, for trades running from 14 June 2019 to 17 March 2020.

Purchases make up the whole of the open-market record (8 purchases, €103k). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2020: 3 purchases and no sales on the market.

A typical purchase (the median) is worth €1,977. The 7 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 17 March 2020, reports an open-market purchase of €183 in Selectimmun. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.